未登录

D

Dorota Nowak

University of Wroclaw

H指数:28

被引数:2,530

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

PFKFB3 and PFKFB4 inhibition modulates the response of metabolically plastic resistant melanoma cells to BRAF/MEK-targeted therapy

PFKFB3和PFKFB4抑制调节代谢可塑性耐药黑色素瘤细胞对BRAF/MEK靶向治疗的反应

Cell Communication and Signaling

IF8.9

2026-09-100

OA

Metabolism alterations accompany the invasive phenotype of melanoma cells resistant to BRAF/MEK inhibitors

黑色素瘤细胞对BRAF/MEK抑制剂的耐药性与侵袭表型的代谢改变相伴发生

Biochimica et Biophysica Acta-Molecular Cell Research

IF3.7

2026-08-010

OAAI

Dedifferentiation and metabolic reprogramming of human adipocytes in the tumor niche triggered by colorectal cancer cells

肿瘤微环境中山结肠癌细胞触发的脂肪细胞去分化与代谢重编程

Biological Research

IF4.6

2025-12-060

OAAI

Stromal cells as a part of tumor microenvironment of melanoma: Their role in cancer progression and drug resistance

ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE

IF1.9

2025-11-010

OA

Phenotype switching in highly invasive resistant to vemurafenib and cobimetinib melanoma cells

vemurafenib和cobimetinib耐药的高侵袭性黑色素瘤细胞的表型转换

Cell Communication and Signaling

IF8.9

2025-10-220

OAAI

Response of Primary Human Adipocytes to Fatty Acid Treatment

原代人类脂肪细胞对脂肪酸处理的反应

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

IF4.2

2025-05-260

OA

The role of adipogenic niche resident cells in colorectal cancer progression in relation to obesity

OBESITY REVIEWS

IF7.4

2025-01-060

OAAI

Characterization of two melanoma cell lines resistant to BRAF/MEK inhibitors (vemurafenib and cobimetinib)

对BRAF/MEK抑制剂 (vemurafenib和cobimetinib) 耐药的两种黑色素瘤细胞系的表征

CELL COMMUNICATION AND SIGNALING

IF8.9

2024-08-231

OAAI

Melanoma cells induce dedifferentiation and metabolic changes in adipocytes present in the tumor niche

CELLULAR & MOLECULAR BIOLOGY LETTERS

IF10.2

2023-07-228

OAAI

Novel hybrid composites based on double-decker silsesquioxanes functionalized by methacrylate derivatives and polyvinyl alcohol as potential materials utilized in biomedical applications

BIOMATERIALS ADVANCES

IF6

2023-03-015

OAAI

Melanoma stimulates the proteolytic activity of HaCaT keratinocytes

CELL COMMUNICATION AND SIGNALING

IF8.9

2022-09-198

OAAI

Melanoma cells with diverse invasive potential differentially induce the activation of normal human fibroblasts

CELL COMMUNICATION AND SIGNALING

IF8.9

2022-05-1025

OAAI

Alpha-Enolase (ENO1) Correlates with Invasiveness of Cutaneous Melanoma-An In Vitro and a Clinical Study

Α-烯醇化酶 (ENO1) 与皮肤黑色素瘤的侵袭性相关-体外和临床研究

IF3.3

2022-01-207

OAAI

The two faces of platinum hydrospirophosphorane complexes-Not only relevant catalysts but cytotoxic compounds as well

APPLIED ORGANOMETALLIC CHEMISTRY

IF0

2021-12-061

PRE

Gelsolin Contributes to the Motility of A375 Melanoma Cells and This Activity Is Mediated by the Fibrous Extracellular Matrix Protein Profile

IF5.2

2021-07-2111

OAAI

Hypoxia and Extracellular Acidification as Drivers of Melanoma Progression and Drug Resistance

IF5.2

2021-04-0936

OAAI

Changes in Biomechanical Properties of A375 Cells Due to the Silencing of TMSB4X Expression Are Not Directly Correlated with Alterations in Their Stemness Features

IF5.2

2021-03-3110

OAAI

PARP1 as a Marker of an Aggressive Clinical Phenotype in Cutaneous Melanoma-A Clinical and an In Vitro Study

IF5.2

2021-01-3113

OAAI

Evaluation of Apelin and Apelin Receptor Level in the Primary Tumor and Serum of Colorectal Cancer Patients

JOURNAL OF CLINICAL MEDICINE

IF2.9

2019-09-2016

OAAI

Evaluation of Drug-Drug Interactions of Rucaparib and CYP1A2, CYP2C9, CYP2C19, CYP3A, and P-gp Substrates in Patients With an Advanced Solid Tumor

CTS-CLINICAL AND TRANSLATIONAL SCIENCE

IF2.8

2018-12-2019

OAAI